v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04778059 |
Full text link
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Jan. 11, 2023, 8 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Jan. 11, 2023, 8 a.m. Source : ClinicalTrials.gov |
Not reported |
Registration date
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2021-03-02 |
Recruitment status
Last imported at : April 23, 2023, midnight Source : ClinicalTrials.gov |
Terminated |
Study design
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: signed informed consent from patient or legal representative; age 18 or greater; positive reverse transcription polymerase chain reaction (rt-pcr) for sars-cov-2 (≤10 days); respiratory rate > 20 rr; spo2 < 94% on room air, requiring supplemental oxygen, requiring invasive mechanical ventilation, or requiring ecmo; chest x-ray confirming bilateral pulmonary infiltrates; body mass index of ≤ 40 units/kg/m2; adequate method of birth control. |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
terminally ill patients due to underlying cardiac, cancer or severe debilitating neurological disease including coma; hospitalization expected to be < 96 hours due to medical improvement; interstitial lung disease; correction of qtc values obtained by 12 lead ekg using fredericia's formula (qtcf) > 450 ms; history of hypotension (mean arterial blood pressure < 65 mmhg), unrelated to covid-19 infection; alanine aminotransferase (alt) or aspartate aminotransferase (ast) > 3 times upper limit of normal; participating concurrently on another clinical trial for the experimental treatment of covid-19; active chemotherapy use; pregnant and/or lactating women. |
Number of arms
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
US Biotest, Inc. |
Inclusion age min
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Aug. 5, 2021, 2:30 p.m. Source : ClinicalTrials.gov |
United States |
Type of patients
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Severe/critical disease at enrollment |
Severity scale
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
7: Severe/critical disease at enrollment |
Total sample size
Last imported at : Jan. 11, 2023, 8 a.m. Source : ClinicalTrials.gov |
21 |
primary outcome
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Number of participants with treatment emergent adverse events (TEAE) |
Notes
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Phase 2 |
Arms
Last imported at : March 4, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": 85, "treatment_name": "Angiotensin 1-7", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}] |